138 related articles for article (PubMed ID: 2411812)
1. Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
Bussolino F; Aglietta M; Sanavio F; Stacchini A; Lauri D; Camussi G
J Immunol; 1985 Oct; 135(4):2748-53. PubMed ID: 2411812
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
Valone FH; Johnson B
J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
4. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)-induced protein phosphorylation in rabbit platelets: inhibitory effects of AGEPC analogs.
Sugatani J; Hanahan DJ
Arch Biochem Biophys; 1986 May; 246(2):855-64. PubMed ID: 3754710
[TBL] [Abstract][Full Text] [Related]
6. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
[TBL] [Abstract][Full Text] [Related]
7. Effects of AGEPC on the intracellular levels of ions in Tetrahymena pyriformis.
Tselepis A; Tsoukatos D; Demopoulos CA; Kapoulas VM
Biochem Int; 1986 Dec; 13(6):999-1008. PubMed ID: 3099798
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
9. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets.
Homma H; Tokumura A; Hanahan DJ
J Biol Chem; 1987 Aug; 262(22):10582-7. PubMed ID: 3038889
[TBL] [Abstract][Full Text] [Related]
10. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs].
Orlov SM; Kulikov VI; Pol'ner AA; Bergel'son LD
Biokhimiia; 1985 Apr; 50(4):680-5. PubMed ID: 2408682
[TBL] [Abstract][Full Text] [Related]
11. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
[TBL] [Abstract][Full Text] [Related]
12. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
Hoffman DR; Hoffman LH; Snyder F
Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways.
Chao W; Liu H; Hanahan DJ; Olson MS
J Biol Chem; 1992 Apr; 267(10):6725-35. PubMed ID: 1551880
[TBL] [Abstract][Full Text] [Related]
15. Specific binding of phospholipid platelet-activating factor by human platelets.
Valone FH; Coles E; Reinhold VR; Goetzl EJ
J Immunol; 1982 Oct; 129(4):1637-41. PubMed ID: 6286773
[TBL] [Abstract][Full Text] [Related]
16. Effect of acetylglyceryl ether phosphocholine (platelet-activating factor) and thrombin on acylation of exogenous lysophosphoglycerides in rabbit platelets.
Piéroni G; Hanahan DJ
Biochim Biophys Acta; 1986 Jun; 877(1):61-7. PubMed ID: 3719000
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat.
Kusner EJ; Knee CD; Krell RD
Agents Actions; 1987 Feb; 20(1-2):61-8. PubMed ID: 3577957
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of platelet-activating factor (alkylacetylphosphocholine) by type-II epithelial cells and fibroblasts from rat lungs.
Kumar R; King RJ; Martin HM; Hanahan DJ
Biochim Biophys Acta; 1987 Jan; 917(1):33-41. PubMed ID: 3790610
[TBL] [Abstract][Full Text] [Related]
19. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
Muzia GI; Kulikov VI
Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands.
Söling HD; Eibl H; Fest W
Eur J Biochem; 1984 Oct; 144(1):65-72. PubMed ID: 6207023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
